New acne pill tested for Long-Term safety in 240 patients
NCT ID NCT06248008
First seen Jan 07, 2026 · Last updated Jun 12, 2026 · Updated 25 times
Summary
This study looked at the long-term safety of a daily pill called ASC40 (Denifanstat) for people with moderate to severe acne. About 240 participants who finished a previous 12-week study took the drug for up to 40 weeks. Researchers tracked side effects and checked if acne improved, but the main goal was to see how safe the drug is over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.